Yili Chuannig Biotechnology Co., Ltd. engages in the research and development, and industrialization of pharmaceutical intermediates in China. It offers antibiotic intermediates, such as thiocyanate erythromycin acid, 7-aminocephalosporanic acid, deacetyl-7-aminocephalosporanic acid, 7-aminodeacetoxycephalosporanic acid, 6-aminopenicillanic acid, penicillium G, potassium salt, etc.; and biomedicine fermentation products, including ursodeoxycholic acid. The company was founded in 2010 and is based in Yining, China.